The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Radiopharmaceuticals in Nuclear Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Radiopharmaceuticals in Nuclear Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Radiopharmaceuticals in Nuclear Medicine market size is estimated to be worth US$ 4943.7 million in 2021 and is forecast to a readjusted size of USD 6857.2 million by 2028 with a CAGR of 4.8% during review period. Diagnostic Application accounting for % of the Radiopharmaceuticals in Nuclear Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Diagnostic Radiopharmaceuticals segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Radiopharmaceuticals in Nuclear Medicine include Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, and Eczacibasi-Monrol, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Radiopharmaceuticals in Nuclear Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Market segment by Application can be divided into
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
The key market players for global Radiopharmaceuticals in Nuclear Medicine market are listed below:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals in Nuclear Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals in Nuclear Medicine, with price, sales, revenue and global market share of Radiopharmaceuticals in Nuclear Medicine from 2019 to 2022.
Chapter 3, the Radiopharmaceuticals in Nuclear Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals in Nuclear Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Radiopharmaceuticals in Nuclear Medicine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals in Nuclear Medicine.
Chapter 13, 14, and 15, to describe Radiopharmaceuticals in Nuclear Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Radiopharmaceuticals in Nuclear Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Radiopharmaceuticals in Nuclear Medicine market size is estimated to be worth US$ 4943.7 million in 2021 and is forecast to a readjusted size of USD 6857.2 million by 2028 with a CAGR of 4.8% during review period. Diagnostic Application accounting for % of the Radiopharmaceuticals in Nuclear Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Diagnostic Radiopharmaceuticals segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Radiopharmaceuticals in Nuclear Medicine include Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, and Eczacibasi-Monrol, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Radiopharmaceuticals in Nuclear Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Market segment by Application can be divided into
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
The key market players for global Radiopharmaceuticals in Nuclear Medicine market are listed below:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals in Nuclear Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals in Nuclear Medicine, with price, sales, revenue and global market share of Radiopharmaceuticals in Nuclear Medicine from 2019 to 2022.
Chapter 3, the Radiopharmaceuticals in Nuclear Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals in Nuclear Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Radiopharmaceuticals in Nuclear Medicine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals in Nuclear Medicine.
Chapter 13, 14, and 15, to describe Radiopharmaceuticals in Nuclear Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Radiopharmaceuticals in Nuclear Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Market Analysis by Application
1.3.1 Overview: Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Global Radiopharmaceuticals in Nuclear Medicine Market Size & Forecast
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume (2017-2028)
1.4.3 Global Radiopharmaceuticals in Nuclear Medicine Price (2017-2028)
1.5 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity Analysis
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Total Production Capacity (2017-2028)
1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Radiopharmaceuticals in Nuclear Medicine Market Drivers
1.6.2 Radiopharmaceuticals in Nuclear Medicine Market Restraints
1.6.3 Radiopharmaceuticals in Nuclear Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging S.P.A.
2.1.1 Bracco Imaging S.P.A. Details
2.1.2 Bracco Imaging S.P.A. Major Business
2.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product and Services
2.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Cambridge Isotope Laboratories, Inc.
2.2.1 Cambridge Isotope Laboratories, Inc. Details
2.2.2 Cambridge Isotope Laboratories, Inc. Major Business
2.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
2.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cardinal Health, Inc.
2.3.1 Cardinal Health, Inc. Details
2.3.2 Cardinal Health, Inc. Major Business
2.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
2.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Covidien, Plc
2.4.1 Covidien, Plc Details
2.4.2 Covidien, Plc Major Business
2.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product and Services
2.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Eczacibasi-Monrol
2.5.1 Eczacibasi-Monrol Details
2.5.2 Eczacibasi-Monrol Major Business
2.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product and Services
2.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Fujifilm Holdings Corporation
2.6.1 Fujifilm Holdings Corporation Details
2.6.2 Fujifilm Holdings Corporation Major Business
2.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
2.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GE Healthcare (Subsidiary Of General Electric Company)
2.7.1 GE Healthcare (Subsidiary Of General Electric Company) Details
2.7.2 GE Healthcare (Subsidiary Of General Electric Company) Major Business
2.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product and Services
2.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 IBA Group
2.8.1 IBA Group Details
2.8.2 IBA Group Major Business
2.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Product and Services
2.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Isotec, Inc. (Sigma-Aldrich)
2.9.1 Isotec, Inc. (Sigma-Aldrich) Details
2.9.2 Isotec, Inc. (Sigma-Aldrich) Major Business
2.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product and Services
2.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lantheus Medical Imaging, Inc.
2.10.1 Lantheus Medical Imaging, Inc. Details
2.10.2 Lantheus Medical Imaging, Inc. Major Business
2.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
2.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Nordion, Inc.
2.11.1 Nordion, Inc. Details
2.11.2 Nordion, Inc. Major Business
2.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
2.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Ntp Radioisotopes (Pty), Ltd.
2.12.1 Ntp Radioisotopes (Pty), Ltd. Details
2.12.2 Ntp Radioisotopes (Pty), Ltd. Major Business
2.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
2.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Siemens Healthcare (Subsidiary Of Siemens AG)
2.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Details
2.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Major Business
2.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product and Services
2.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Taiyo Nippon Sanso Corporation
2.14.1 Taiyo Nippon Sanso Corporation Details
2.14.2 Taiyo Nippon Sanso Corporation Major Business
2.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
2.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Urenco Limited
2.15.1 Urenco Limited Details
2.15.2 Urenco Limited Major Business
2.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product and Services
2.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Rotem Industries, Ltd., Inc.
2.16.1 Rotem Industries, Ltd., Inc. Details
2.16.2 Rotem Industries, Ltd., Inc. Major Business
2.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
2.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Australian Nuclear Association And Technology Organization (ANSTO)
2.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Details
2.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Major Business
2.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product and Services
2.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Board of Radiation And Isotope Technology (BRIT)
2.18.1 Board of Radiation And Isotope Technology (BRIT) Details
2.18.2 Board of Radiation And Isotope Technology (BRIT) Major Business
2.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product and Services
2.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Institute of Atomic Energy Polatom Radioisotope Centre
2.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Details
2.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Major Business
2.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product and Services
2.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Institute of Isotopes Co., Ltd.
2.20.1 Institute of Isotopes Co., Ltd. Details
2.20.2 Institute of Isotopes Co., Ltd. Major Business
2.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
2.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Institute Of Radioelement (IRE)
2.21.1 Institute Of Radioelement (IRE) Details
2.21.2 Institute Of Radioelement (IRE) Major Business
2.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product and Services
2.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Radiopharmaceuticals in Nuclear Medicine Breakdown Data by Manufacturer
3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Radiopharmaceuticals in Nuclear Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2021
3.4.2 Top 6 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2021
3.5 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Radiopharmaceuticals in Nuclear Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Region (2017-2028)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2028)
4.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
4.3 Europe Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
4.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
4.5 South America Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
4.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Type (2017-2028)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Application (2017-2028)
6.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028)
6.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
7.2 North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
7.3 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
7.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Country (2017-2028)
7.3.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
8.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
8.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country
8.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Country (2017-2028)
8.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
9.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
9.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
10.2 South America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
10.3 South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
10.3.1 South America Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Country (2017-2028)
10.3.2 South America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
11.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
11.3 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Radiopharmaceuticals in Nuclear Medicine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Radiopharmaceuticals in Nuclear Medicine
12.3 Radiopharmaceuticals in Nuclear Medicine Production Process
12.4 Radiopharmaceuticals in Nuclear Medicine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Radiopharmaceuticals in Nuclear Medicine Typical Distributors
13.3 Radiopharmaceuticals in Nuclear Medicine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bracco Imaging S.P.A. Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging S.P.A. Major Business
Table 5. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 6. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Cambridge Isotope Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Cambridge Isotope Laboratories, Inc. Major Business
Table 9. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 10. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Cardinal Health, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Cardinal Health, Inc. Major Business
Table 13. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 14. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Covidien, Plc Basic Information, Manufacturing Base and Competitors
Table 16. Covidien, Plc Major Business
Table 17. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 18. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Eczacibasi-Monrol Basic Information, Manufacturing Base and Competitors
Table 20. Eczacibasi-Monrol Major Business
Table 21. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 22. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Fujifilm Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Fujifilm Holdings Corporation Major Business
Table 25. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 26. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Manufacturing Base and Competitors
Table 28. GE Healthcare (Subsidiary Of General Electric Company) Major Business
Table 29. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 30. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. IBA Group Basic Information, Manufacturing Base and Competitors
Table 32. IBA Group Major Business
Table 33. IBA Group Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 34. IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Isotec, Inc. (Sigma-Aldrich) Basic Information, Manufacturing Base and Competitors
Table 36. Isotec, Inc. (Sigma-Aldrich) Major Business
Table 37. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 38. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lantheus Medical Imaging, Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Lantheus Medical Imaging, Inc. Major Business
Table 41. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 42. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Nordion, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Nordion, Inc. Major Business
Table 45. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 46. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Ntp Radioisotopes (Pty), Ltd. Basic Information, Manufacturing Base and Competitors
Table 48. Ntp Radioisotopes (Pty), Ltd. Major Business
Table 49. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 50. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Siemens Healthcare (Subsidiary Of Siemens AG) Basic Information, Manufacturing Base and Competitors
Table 52. Siemens Healthcare (Subsidiary Of Siemens AG) Major Business
Table 53. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 54. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Taiyo Nippon Sanso Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Taiyo Nippon Sanso Corporation Major Business
Table 57. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 58. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Urenco Limited Basic Information, Manufacturing Base and Competitors
Table 60. Urenco Limited Major Business
Table 61. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 62. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Rotem Industries, Ltd., Inc. Basic Information, Manufacturing Base and Competitors
Table 64. Rotem Industries, Ltd., Inc. Major Business
Table 65. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 66. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Australian Nuclear Association And Technology Organization (ANSTO) Basic Information, Manufacturing Base and Competitors
Table 68. Australian Nuclear Association And Technology Organization (ANSTO) Major Business
Table 69. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 70. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Board of Radiation And Isotope Technology (BRIT) Basic Information, Manufacturing Base and Competitors
Table 72. Board of Radiation And Isotope Technology (BRIT) Major Business
Table 73. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 74. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Institute of Atomic Energy Polatom Radioisotope Centre Basic Information, Manufacturing Base and Competitors
Table 76. Institute of Atomic Energy Polatom Radioisotope Centre Major Business
Table 77. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 78. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Institute of Isotopes Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Institute of Isotopes Co., Ltd. Major Business
Table 81. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 82. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Institute Of Radioelement (IRE) Basic Information, Manufacturing Base and Competitors
Table 84. Institute Of Radioelement (IRE) Major Business
Table 85. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 86. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 88. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 89. Market Position of Manufacturers in Radiopharmaceuticals in Nuclear Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 90. Global Radiopharmaceuticals in Nuclear Medicine Production Capacity by Company, (K MT): 2020 VS 2021
Table 91. Head Office and Radiopharmaceuticals in Nuclear Medicine Production Site of Key Manufacturer
Table 92. Radiopharmaceuticals in Nuclear Medicine New Entrant and Capacity Expansion Plans
Table 93. Radiopharmaceuticals in Nuclear Medicine Mergers & Acquisitions in the Past Five Years
Table 94. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022) & (K MT)
Table 95. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2023-2028) & (K MT)
Table 96. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022) & (USD Million)
Table 97. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2023-2028) & (USD Million)
Table 98. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 99. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 100. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (USD Million)
Table 101. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (USD Million)
Table 102. Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2022) & (USD/MT)
Table 103. Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2023-2028) & (USD/MT)
Table 104. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 105. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 106. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (USD Million)
Table 107. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (USD Million)
Table 108. Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2017-2022) & (USD/MT)
Table 109. Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2023-2028) & (USD/MT)
Table 110. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)
Table 111. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT)
Table 112. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (USD Million)
Table 113. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (USD Million)
Table 114. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 115. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 116. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 117. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 118. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)
Table 119. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT)
Table 120. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (USD Million)
Table 121. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (USD Million)
Table 122. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 123. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 124. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 125. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 126. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022) & (K MT)
Table 127. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2023-2028) & (K MT)
Table 128. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022) & (USD Million)
Table 129. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2023-2028) & (USD Million)
Table 130. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 131. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 132. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 133. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 134. South America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT)
Table 135. South America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT)
Table 136. South America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (USD Million)
Table 137. South America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (USD Million)
Table 138. South America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 139. South America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 140. South America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 141. South America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 142. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022) & (K MT)
Table 143. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Region (2023-2028) & (K MT)
Table 144. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022) & (USD Million)
Table 145. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2023-2028) & (USD Million)
Table 146. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT)
Table 147. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT)
Table 148. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT)
Table 149. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT)
Table 150. Radiopharmaceuticals in Nuclear Medicine Raw Material
Table 151. Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine Raw Materials
Table 152. Direct Channel Pros & Cons
Table 153. Indirect Channel Pros & Cons
Table 154. Radiopharmaceuticals in Nuclear Medicine Typical Distributors
Table 155. Radiopharmaceuticals in Nuclear Medicine Typical Customers
List of Figures
Figure 1. Radiopharmaceuticals in Nuclear Medicine Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type in 2021
Figure 3. Diagnostic Radiopharmaceuticals
Figure 4. Therapy Radiopharmaceuticals
Figure 5. Enriched Stable Isotopes
Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application in 2021
Figure 7. Diagnostic Application
Figure 8. Therapeutic Application
Figure 9. Research
Figure 10. Pharmaceutical
Figure 11. Other
Figure 12. Global Radiopharmaceuticals in Nuclear Medicine Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 13. Global Radiopharmaceuticals in Nuclear Medicine Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Sales (2017-2028) & (K MT)
Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Price (2017-2028) & (USD/MT)
Figure 16. Global Radiopharmaceuticals in Nuclear Medicine Production Capacity (2017-2028) & (K MT)
Figure 17. Global Radiopharmaceuticals in Nuclear Medicine Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Radiopharmaceuticals in Nuclear Medicine Market Drivers
Figure 19. Radiopharmaceuticals in Nuclear Medicine Market Restraints
Figure 20. Radiopharmaceuticals in Nuclear Medicine Market Trends
Figure 21. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturer in 2021
Figure 22. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturer in 2021
Figure 23. Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Radiopharmaceuticals in Nuclear Medicine Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Radiopharmaceuticals in Nuclear Medicine Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2028)
Figure 27. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2017-2028)
Figure 28. North America Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (USD Million)
Figure 29. Europe Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (USD Million)
Figure 31. South America Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (USD Million)
Figure 33. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 34. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028)
Figure 35. Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2028) & (USD/MT)
Figure 36. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 37. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028)
Figure 38. Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2017-2028) & (USD/MT)
Figure 39. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 40. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 41. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2017-2028)
Figure 42. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2017-2028)
Figure 43. United States Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 47. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 48. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2017-2028)
Figure 49. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2017-2028)
Figure 50. Germany Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2017-2028)
Figure 59. China Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 66. South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 67. South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2017-2028)
Figure 68. South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medicine in 2021
Figure 80. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
Figure 81. Radiopharmaceuticals in Nuclear Medicine Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
